Skip to main content
Caplight Logo









Ridgeback Capital

Ridgeback Capital

New York City, New Yorkridgebackcap.com

Overview

Ridgeback Capital is an actively managed private investment company that specializes in both securities trading and long-term private investment, with a specialized focus on investing in life science companies . The firm invests in private and public companies dedicated to the development of life-saving and life-changing therapies .

Year Founded

2006

AUM

$560M

Portfolio Companies

12

Investments

Ridgeback Capital investments
CompanyDateStageLead
FreenomeDec 2021Series D-
Senti BiosciencesJan 2021Series BCo-investor
Arbor BiotechnologiesNov 2021Series B-
Hinge BioJan 2025Series ACo-investor
Quell TherapeuticsNov 2021Series BLead
Book a demo to see all investments

For institutional investors. Book with your work email.

Key People

Wayne Holman

Founder CEO

Jeffrey Long-McGie

Managing Director Analyst (Private Investments)

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is Ridgeback Capital based?

Ridgeback Capital is headquartered in New York City, New York, United States.

When was Ridgeback Capital founded?

Ridgeback Capital was founded in 2006.

How many portfolio companies does Ridgeback Capital have?

Ridgeback Capital has 12 portfolio companies in Caplight's dataset.

What are some companies in Ridgeback Capital's portfolio?

Portfolio companies visible on Caplight include Freenome, Senti Biosciences, Arbor Biotechnologies, Hinge Bio, Quell Therapeutics.

What was Ridgeback Capital's most recent investment shown here?

Ridgeback Capital's most recent investment in this portfolio sample was in Hinge Bio in 2025.

What sectors does Ridgeback Capital focus on?

Ridgeback Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.

What company stages does Ridgeback Capital focus on?

Ridgeback Capital typically invests at the Early stage.

What is Ridgeback Capital's AUM?

Ridgeback Capital's assets under management are estimated between $500.0M and $1.0B.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2006
AUM$560M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?